short introduction about microbiology with classification of microorganism, isolation methods, information about staining techniques. those information related to diploma students
short introduction about microbiology with classification of microorganism, isolation methods, information about staining techniques. those information related to diploma students
Epidemiology and Characterization of lipophilic yeast (Malassezia) from human...Premier Publishers
Accurate identifications of the species are needed to obtain a better understanding of the role of each individual species in the etiology of disease. Increased number of species under the genus Malassezia, urges to characterize the lipophilic yeasts distribution, dominant species from human dandruff samples. This study aimed at the prevalence of Malassezia species in selected individuals and their identification using morphological, biochemical methods along with molecular characterization. Culture based techniques such as catalase test, tween assimilation, esculin hydrolysis and glycine assimilation were performed and the results revealed that 22 isolates were M. globosa, 12 were M. furfur, 9 were M. sympodialis, 4 were M. obtusa and 3 were M. restricta out of 50 positive samples. PCR-RFLP method was used for the specific identification of the Malassezia isolates. 26S rDNA PCR Products after digestion with CfoI and BstF51 revealed differences between the isolates described the species distribution of Malassezia in dandruff samples to overcome diagnostic limitations.
Journal of Bacteriology and Mycology is a peer-reviewed, open access journal published by Austin Publishers. It provides easy access to high quality manuscripts in all related aspects of two major sub branches of Microbiology namely Bacteriology: the study of Bacterial Mycology& the study of fungus. The Journal focuses upon the identification, classification, characterization of bacterial/fungal species and the infections and health issues caused by these dreadful bacteria and fungus.
Austin Publishing Group is a successful host of more than hundred peer reviewed journals, open access journals in various fields of science and technology with intent to bridge the gap between academic and research access.
Journal of Bacteriology and Mycology journal accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials in all related aspects of Bacterial Mycology & Fungal Species.
Diagnosis of fungal disease by Dr. Manoj karkimanojj123
Early diagnosis of fungal infection is critical for effective treatment. History, clinical signs, gross pathology and in few cases intradermal skin test are all of the value in the diagnosis of clinical specimens.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
10. Features
• Largest lizard on Earth
• May live up to 100 years
• Can run 20 kilometers per hour
• Dive upto 4.5 meters ( 15 feets) deep in water
• Kills its prey with a lethal bite
• Believed to inject toxic substance into the
blood stream of the animals
• Saliva contains potent and complex venom
11.
12.
13. Primary goal of the research was to
characterize the antibacterial
properties of Serum from the
Komodo Dragon
22. • Collected from komodo Dragons at the Houstan
and San Antonio Zoo.
• Collected from 3 adults of weight 20 – 81.5 kg
• Collected from 5 juveniles of weight 1.5-6.2 kg
• Drawn from the tail vein
• Transferred to vaccutainer tube
• Allowed to clot for 5 hours before collecting the
serum.
• Serum was pooled so that the average
antibacterial values can be generated
• Stored at -20’C until used for bacterial assay.
25. • Took 200 samples of serum containing
volumes of 20-200 ul in micro-titer plates.
• The plates were then inoculated with 5ul of
bacterial culture.
• Then the samples were incubated for 24 hours
at 37’C.
• Optical density of each sample was measured
at 0,3,6,12 and 24 hour using Benchmark Plus
micro-titer plate reader at 430 nm.
27. • 500 ul of Komodo Dragon serum was inoculated
with 20 ul of an E.Coli culture in log phase
growth.
• 50 dilution of each sample were spread onto the
surface of Nutrient Broth agar plates to
determine the CFU’s for each sample.
• To determine the possible antibacterial
mechanism, pooled serum was incubated with
pronase ( isolated from Streptomyces Griseus), 5
mm EDTA or 5 mm phosphate for 30 minutes at
ambient temperature.
30. Results for Gram Negative Bacteria
• 10% of Komodoensis serum produced 44% decrease in
E.Coli growth.
• 25% of serum produced 58% decrease in E.Coli growth.
• 50% of serum poduced 75% decrease in E.Coli growth.
• 75% of serum produced 93% decrease in E.Coli growth
• 100% of serum produced 98% decrease in E.Coli
growth
• 1 ul of serum has the capacity to kill approximately
2.24 million of E.Coli bacteria.
31. • 25% of serum produced 65% decrease in
Klebsiella Oxytoca.
• 58% of serum completely inhibited the
growth of Klebsiella Oxytoca in 24 hours.
• 10% of Serum inhibited Shigella Flexneri and
Salmonella Typhimurium by 95% at 24 hours
• Providencia Staurti’s growth is completely
inhibited by 10% Komodoensis serum.
32. Results for Gram Positive Bacteria
• 10% of komodoensis serum inhibited the growth
of Staphylococcus Aureus by 64 % at 24 hours.
• 25% of serum inhibited 68% growth of
Staphylococcus.
• 50% of serum inhibited 84% growth of
Staphylococcus.
• 75% of serum inhibited 94% growth of
Staphylococcus.
• 10% of serum inhibited 49% growth of
Streptococcus Epidermitis
34. • Antibacterial activity occurred quickly as 18% of
the bacteria (2.95 million) were killed in 5 mins.
• Further incubation resulted in 43% (7.05 million)
of the bacteria killed in 10 mins after the
exposure to serum
• In 20 mins 68% (11.2 million) of E.coli bacteria
were killed.
• Treatment of serum with 5 Mm EDTA or 5 Mm of
Phosphate only resulted in 6.3% or 8.7% of the
antibacterial activity.
35. • This activity of Serum suggests that Komodo
Dragon are resistant to Microbial Infections.
• It would be reasonable to expect the Komodo
Dragons would have developed Innate
Immune Mechanisms to combat possible
infections by the bacteria in their own Saliva.
36. • Before this study ,crocodilians were
considered to have the most potent serum
complement defense system.
• The result in this study show that the potency
of Komodo Dragon serum is much higher than
the crocodilians